Your browser doesn't support javascript.
Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature.
Takao, Hiroyuki; Iijima, Hiroyuki; Odagiri, Rika; Hayakawa, Itaru; Ogimi, Chikara.
  • Takao H; Center for Postgraduate Education and Training, National Center for Child Health and Development, Tokyo, Japan; Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Iijima H; Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan. Electronic address: iijima-hi@ncchd.go.jp.
  • Odagiri R; Center for Postgraduate Education and Training, National Center for Child Health and Development, Tokyo, Japan; Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Hayakawa I; Division of Neurology, National Center for Child Health and Development, Tokyo, Japan.
  • Ogimi C; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
J Infect Chemother ; 29(8): 792-795, 2023 Aug.
Article in English | MEDLINE | ID: covidwho-2304509
ABSTRACT
Acute coronavirus disease 2019 (COVID-19)-associated cerebellar ataxia without multisystem inflammatory syndrome in children (MIS-C) or encephalopathy in children has been rarely reported. We reviewed medical records of hospitalized children who had developed cerebellar ataxia during the acute phase of COVID-19 infection, without MIS-C or encephalopathy, in our center. We also conducted a literature review and summarized the clinical characteristics, treatment, and outcomes. We found three cases in our center and additional three cases in the literature. All patients were male and five were preschool children. The cerebellar symptoms started between day 2 and day 10 during the acute phase of the COVID-19 infection. Two cases were complicated by mutism. One patient received therapy for acute cerebellar ataxia with corticosteroids, and others did not receive any specific therapy for acute cerebellar ataxia. The symptoms improved completely in all patients, with the recovery interval ranging from one week to two months. Further studies are warranted to elucidate the pathogenesis of acute cerebellar ataxia during acute COVID-19 in children.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Brain Diseases / Cerebellar Ataxia / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study / Reviews Topics: Long Covid Limits: Child, preschool / Female / Humans / Male Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2023 Document Type: Article Affiliation country: J.jiac.2023.04.003

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Brain Diseases / Cerebellar Ataxia / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study / Reviews Topics: Long Covid Limits: Child, preschool / Female / Humans / Male Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2023 Document Type: Article Affiliation country: J.jiac.2023.04.003